Oliver Königsbrügge, MD PhD

Physician Scientist
Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria

I, Oliver Königsbrügge MD PhD, am a physician scientist at the Medical University of Vienna, Department of Medicine I, Clinical Division of Hematology and Hemostaseology.
My clinical work includes malignant and benign hematology and inherited and acquired coagulation and bleeding disorders.
There are two areas of research I would like to focus on:
- Anticoagulation in vulnerable and high risk patient populations (cancer patients, hemodialysis patients)
- Hemophilia A and B: Laboratory issues regarding treatment

Presentation(s):

• PB0429 - Impact of venous thromboembolism on physical functioning: Results from a prospective cohort study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 45.1 - Circulatory microRNA-411-5p as a novel prognostic biomarker for major adverse cardiac events in patients with atrial fibrillation

  Monday, July 11, 2022
  2:45 PM – 3:00 PM

• PB0499 - Bleeding risk assessment in end-stage kidney disease: validation of existing risk scores and evaluation of a machine learning-based approach

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0500 - Frequency, reasons and duration of hospitalization in patients with end-stage kidney disease on hemodialysis: Prospective results of VIVALDI

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0521 - Use of antithrombotic agents for the prevention of coronary and peripheral arterial events in patients with end-stage kidney disease on hemodialysis: Prospective results of the VIVALDI study

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0914 - Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB1138 - Obesity, fibrinolysis, and bleeding in patients with non-severe hemophilia

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM